Careers
Contact Us
Healthcare Professionals
About Us
Management Team
Board of Directors
Scientific Advisory Board
Our Product
Our Science
Publications and Presentations
Clinical Trials – LOCK-IT 100
Learn More About CRBSIs
Visit CRBSIs.com
Investors
Investors
Press Releases
In the News
Presentations and Events
Investor FAQ
Analyst Coverage
Corporate Governance
SEC Filings
Healthcare Professionals
Careers
Contact Us
Home
>
Investors & Media
Press Releases
Review corporate releases related to governance, investor news, and other important announcements.
All
2025
2024
2023
2022
2021
2020
2019
2018
Nov 12, 2025
CORMEDIX INC. REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND UPDATES FY 2025 GUIDANCE
Read more
Oct 31, 2025
CORMEDIX INC. TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 12, 2025
Read more
Oct 23, 2025
CORMEDIX INC. RECEIVES INNOVATIVE TECHNOLOGY DESIGNATION FROM VIZIENT FOR DEFENCATH
Read more
Oct 20, 2025
CORMEDIX INC. ANNOUNCES PRELIMINARY THIRD QUARTER 2025 RESULTS AND RAISES 2025 NET REVENUE GUIDANCE
Read more
Sep 29, 2025
CORMEDIX ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE III RESPECT CLINICAL TRIAL FOR REZZAYO
Read more
Sep 08, 2025
CORMEDIX ANNOUNCES STRATEGIC MINORITY INVESTMENT IN TALPHERA
Read more
Sep 02, 2025
CORMEDIX COMPLETES ACQUISITION OF MELINTA THERAPEUTICS, RAISES FINANCIAL GUIDANCE AND ANNOUNCES NEW LEADERSHIP TEAM
Read more
Aug 28, 2025
CORMEDIX TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Read more
Aug 07, 2025
CORMEDIX TO ACQUIRE MELINTA THERAPEUTICS, CREATING DIVERSIFIED SPECIALTY COMPANY WITH STRONG PRESENCE IN ACUTE CARE SETTINGS
Read more
CORMEDIX INC. REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Read more
See more
You have clicked on an external link and will be taken offsite.
Would you like to proceed?
CONTINUE
Cancel